MedPath

Fractional picosecond 1,064 nanometer laser versus fractional radiofrequency in the treatment of acne scars: a split-face double-blinded randomized control trial

Phase 4
Recruiting
Conditions
Patients with acne scars (superficial and deep boxcar)
fractional picosecond 1,064 nanometer laser, fractional radiofrequency, acne scars
Registration Number
TCTR20210730003
Lead Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
35
Inclusion Criteria

1. Patients with acne scars (superficial and deep boxcar) at face for at least 3 months
2. Fitzpatrick skin type III-V

Exclusion Criteria

1. Patients with photosensitive dermatoses, history of skin cancer, keloid, immunodeficiency, infection/inflammation at the tested area
2. Patients who routinely smoke
3. Pregnancy
4. Receiving acne scars treatment such as AHA, retinoic acid 6 months prior to enrollment
5. Had laser or radiofrequency treatment 3 months prior to enrollment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.